Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer

Cancer Immunol Res. 2015 Aug;3(8):849-54. doi: 10.1158/2326-6066.CIR-15-0100. Epub 2015 Jun 29.

Abstract

The costimulatory molecules B7-H3 and B7-H4 are overexpressed in a variety of human tumors and have been hypothesized as possible biomarkers and immunotherapeutic targets. Despite this potential, the predominating uncertainty about their functional implication in tumor-host interaction hampers their evaluation as a target for cancer therapy. By means of a highly physiologic, spontaneous tumor model in mice, we establish a causal link between B7-H3 and host tumor control and found B7-H4 to be redundant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B7 Antigens / genetics*
  • B7 Antigens / metabolism
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / metabolism
  • Disease Models, Animal
  • Gene Deletion*
  • Humans
  • Immunophenotyping
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphocytes, Tumor-Infiltrating / metabolism
  • Male
  • Mice
  • Mice, Knockout
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / immunology
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / pathology*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Tumor Burden
  • V-Set Domain-Containing T-Cell Activation Inhibitor 1 / genetics*
  • V-Set Domain-Containing T-Cell Activation Inhibitor 1 / metabolism

Substances

  • B7 Antigens
  • Cd276 protein, mouse
  • RNA, Messenger
  • V-Set Domain-Containing T-Cell Activation Inhibitor 1
  • Vtcn1 protein, mouse